{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T08:39:37Z","timestamp":1768466377937,"version":"3.49.0"},"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2013,11,18]],"date-time":"2013-11-18T00:00:00Z","timestamp":1384732800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0078780","type":"journal-article","created":{"date-parts":[[2013,11,19]],"date-time":"2013-11-19T03:35:34Z","timestamp":1384832134000},"page":"e78780","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["Regulatory Effects of Sestrin 3 (SESN3) in BCR-ABL Expressing Cells"],"prefix":"10.1371","volume":"8","author":[{"given":"Eliza","family":"Vakana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet Dirim","family":"Arslan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Szilard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica K.","family":"Altman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonidas C.","family":"Platanias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,11,18]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1182\/blood-2008-07-077958","article-title":"Translation of the Philadelphia chromosome into therapy for CML","volume":"112","author":"BJ Druker","year":"2008","journal-title":"Blood"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1056\/NEJMoa062867","article-title":"Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia","volume":"355","author":"BJ Druker","year":"2006","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1126\/science.2408149","article-title":"Tyrosine kinase activity and transformation potency of bcr-abl oncogene products","volume":"247","author":"TG Lugo","year":"1990","journal-title":"Science"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3109\/10428194.2010.546919","article-title":"Regulation of mammalian target of rapamycin and mitogen activated protein kinase pathways by BCR-ABL","volume":"52 Suppl 1","author":"AJ Redig","year":"2011","journal-title":"Leuk Lymphoma"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1182\/blood-2004-03-0849","article-title":"Activation of the PI3K\/mTOR pathway by BCR-ABL contributes to increased production of reactive oxygen species","volume":"105","author":"JH Kim","year":"2005","journal-title":"Blood"},{"key":"ref6","first-page":"5716","article-title":"Bcr-Abl kinase modulates the translation regulators ribosomal protein S6 and 4E-BP1 in chronic myelogenous leukemia cells via the mammalian target of rapamycin","volume":"63","author":"C Ly","year":"2003","journal-title":"Cancer Res"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1073\/pnas.0400063101","article-title":"Combination of rapamycin and protein tyrosine kinase (PTK) inhibitors for the treatment of leukemias caused by oncogenic PTKs","volume":"101","author":"MG Mohi","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref8","first-page":"3065","article-title":"Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer","volume":"118","author":"A Carracedo","year":"2008","journal-title":"J Clin Invest"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1182\/blood-2005-09-3732","article-title":"A MAPK\/HNRPK pathway controls BCR\/ABL oncogenic potential by regulating MYC mRNA translation","volume":"107","author":"M Notari","year":"2006","journal-title":"Blood"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nm0596-561","article-title":"Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells","volume":"2","author":"BJ Druker","year":"1996","journal-title":"Nat Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1172\/JCI31988","article-title":"Applying the discovery of the Philadelphia chromosome","volume":"117","author":"DW Sherbenou","year":"2007","journal-title":"J Clin Invest"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"5011","DOI":"10.1182\/blood-2006-01-015347","article-title":"Identification of BCR-ABL point mutations conferring resistance to the Abl kinase inhibitor AMN107 (nilotinib) by a random mutagenesis study","volume":"109","author":"A Ray","year":"2007","journal-title":"Blood"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1182\/blood-2005-12-010132","article-title":"Bcr-Abl resistance screening predicts a limited spectrum of point mutations to be associated with clinical resistance to the Abl kinase inhibitor nilotinib (AMN107)","volume":"108","author":"N von Bubnoff","year":"2006","journal-title":"Blood"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1182\/asheducation-2009.1.461","article-title":"Mechanisms of resistance to tyrosine kinase inhibitors in chronic myeloid leukemia and recent therapeutic strategies to overcome resistance","volume":"1","author":"D Bixby","year":"2009","journal-title":"Hematology"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1056\/NEJMoa1205127","article-title":"Ponatinib in refractory Philadelphia chromosome-positive leukemias","volume":"367","author":"JE Cortes","year":"2012","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1158\/1078-0432.CCR-09-3314","article-title":"Targeting the BCR-ABL signaling pathway in therapy-resistant Philadelphia chromosome-positive leukemia","volume":"17","author":"T O'Hare","year":"2011","journal-title":"Clin Cancer Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"E125","DOI":"10.1002\/ajh.23338","article-title":"Three novel patient-derived BCR\/ABL mutants show different sensitivity to second and third generation tyrosine kinase inhibitors","volume":"87","author":"S Redaelli","year":"2012","journal-title":"Am J Hematol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"34227","DOI":"10.1074\/jbc.M402290200","article-title":"A Bcr\/Abl-independent, Lyn-dependent form of imatinib mesylate (STI-571) resistance is associated with altered expression of Bcl-2","volume":"279","author":"Y Dai","year":"2004","journal-title":"J Biol Chem"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1182\/blood.V101.2.690","article-title":"BCR-ABL independence and LYN kinase overexpression in chronic myelogenous leukemia cells selected for resistance to STI571","volume":"101","author":"NJ Donato","year":"2003","journal-title":"Blood"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/ng1343","article-title":"Requirement of Src kinases Lyn, Hck and Fgr for BCR-ABL1-induced B-lymphoblastic leukemia but not chronic myeloid leukemia","volume":"36","author":"Y Hu","year":"2004","journal-title":"Nat Genet"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"24273","DOI":"10.1074\/jbc.M002094200","article-title":"The BCR\/ABL tyrosine kinase induces production of reactive oxygen species in hematopoietic cells","volume":"275","author":"M Sattler","year":"2000","journal-title":"J Biol Chem"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1038\/leu.2009.49","article-title":"Bcr-Abl-mediated redox regulation of the PI3K\/AKT pathway","volume":"23","author":"R Naughton","year":"2009","journal-title":"Leukemia"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.cmet.2010.05.001","article-title":"With TOR, less is more: a key role for the conserved nutrient-sensing TOR pathway in aging","volume":"11","author":"P Kapahi","year":"2010","journal-title":"Cell Metab"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.devcel.2007.03.020","article-title":"The two TORCs and Akt","volume":"12","author":"PT Bhaskar","year":"2007","journal-title":"Dev Cell"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1038\/onc.2010.139","article-title":"Targeting mTOR: prospects for mTOR complex 2 inhibitors in cancer therapy","volume":"29","author":"CA Sparks","year":"2010","journal-title":"Oncogene"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nri1604","article-title":"Mechanisms of type-I- and type-II-interferon-mediated signalling","volume":"5","author":"LC Platanias","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"ref27","article-title":"The evolution of the TOR pathway and its role in cancer","author":"EM Beauchamp","year":"2012","journal-title":"Oncogene"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"12469","DOI":"10.1073\/pnas.1005114107","article-title":"Critical roles for mTORC2- and rapamycin-insensitive mTORC1-complexes in growth and survival of BCR-ABL-expressing leukemic cells","volume":"107","author":"N Carayol","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nm.2091","article-title":"Effective and selective targeting of leukemia cells using a TORC1\/2 kinase inhibitor","volume":"16","author":"MR Janes","year":"2010","journal-title":"Nat Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/emmm.201000097","article-title":"Stressin' Sestrins take an aging fight","volume":"2","author":"AV Budanov","year":"2010","journal-title":"EMBO Mol Med"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1126\/science.1095569","article-title":"Regeneration of peroxiredoxins by p53-regulated sestrins, homologs of bacterial AhpD","volume":"304","author":"AV Budanov","year":"2004","journal-title":"Science"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.cell.2008.06.028","article-title":"p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling","volume":"134","author":"AV Budanov","year":"2008","journal-title":"Cell"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.cmet.2008.08.010","article-title":"p53 strikes mTORC1 by employing sestrins","volume":"8","author":"N Hay","year":"2008","journal-title":"Cell Metab"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.devcel.2010.03.008","article-title":"FoxOs inhibit mTORC1 and activate Akt by inducing the expression of Sestrin3 and Rictor","volume":"18","author":"CC Chen","year":"2010","journal-title":"Dev Cell"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.ccr.2008.11.003","article-title":"Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis","volume":"14","author":"V Nogueira","year":"2008","journal-title":"Cancer Cell"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"4671","DOI":"10.1158\/0008-5472.CAN-06-2466","article-title":"Repression of sestrin family genes contributes to oncogenic Ras-induced reactive oxygen species up-regulation and genetic instability","volume":"67","author":"PB Kopnin","year":"2007","journal-title":"Cancer Res"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1126\/science.1182228","article-title":"Sestrin as a feedback inhibitor of TOR that prevents age-related pathologies","volume":"327","author":"JH Lee","year":"2010","journal-title":"Science"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"6017","DOI":"10.1038\/sj.onc.1205877","article-title":"Identification of a novel stress-responsive gene Hi95 involved in regulation of cell viability","volume":"21","author":"AV Budanov","year":"2002","journal-title":"Oncogene"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"6399","DOI":"10.1182\/blood-2011-01-332783","article-title":"Antileukemic effects of AMPK activators on BCR-ABL expressing cells","volume":"118","author":"E Vakana","year":"2011","journal-title":"Blood"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1074\/jbc.M607365200","article-title":"Regulatory effects of mammalian target of rapamycin-activated pathways in type I and II interferon signaling","volume":"282","author":"S Kaur","year":"2007","journal-title":"J Biol Chem"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1124\/mol.109.061507","article-title":"Arsenic trioxide-dependent activation of thousand-and-one amino acid kinase 2 and transforming growth factor-beta-activated kinase 1","volume":"77","author":"JL McNeer","year":"2010","journal-title":"Mol Pharmacol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0022-1759(00)00156-3","article-title":"Superoxide produced by activated neutrophils efficiently reduces the tetrazolium salt, WST-1 to produce a soluble formazan: a simple colorimetric assay for measuring respiratory burst activation and for screening anti-inflammatory agents","volume":"238","author":"AS Tan","year":"2000","journal-title":"J Immunol Methods"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"8601","DOI":"10.1074\/jbc.M707934200","article-title":"Suppression of programmed cell death 4 (PDCD4) protein expression by BCR-ABL-regulated engagement of the mTOR\/p70 S6 kinase pathway","volume":"283","author":"N Carayol","year":"2008","journal-title":"J Biol Chem"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1182\/blood-2004-10-4003","article-title":"Differential regulation of the p70 S6 kinase pathway by interferon alpha (IFNalpha) and imatinib mesylate (STI571) in chronic myelogenous leukemia cells","volume":"106","author":"S Parmar","year":"2005","journal-title":"Blood"},{"key":"ref45","first-page":"1","article-title":"ON012380, a putative BCR-ABL kinase inhibitor with a unique mechanism of action in imatinib-resistant cells","author":"J Wu","year":"2010","journal-title":"Leukemia"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.cmet.2012.08.004","article-title":"Maintenance of metabolic homeostasis by Sestrin2 and Sestrin3","volume":"16","author":"JH Lee","year":"2012","journal-title":"Cell Metab"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"e32035","DOI":"10.1371\/journal.pone.0032035","article-title":"Sestrin2 modulates AMPK subunit expression and its response to ionizing radiation in breast cancer cells","volume":"7","author":"T Sanli","year":"2012","journal-title":"PloS one"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1172\/JCI33337","article-title":"Ablation of PI3K blocks BCR-ABL leukemogenesis in mice, and a dual PI3K\/mTOR inhibitor prevents expansion of human BCR-ABL+ leukemia cells","volume":"118","author":"MG Kharas","year":"2008","journal-title":"J Clin Invest"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/jcb.23369","article-title":"Targeting AMPK in the treatment of malignancies","volume":"113","author":"E Vakana","year":"2011","journal-title":"J Cell Biochem"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0078780","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T23:40:02Z","timestamp":1540338002000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0078780"}},"subtitle":[],"editor":[{"given":"Kevin D.","family":"Bunting","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,11,18]]},"references-count":49,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2013,11,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0078780","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,18]]}}}